3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Colorectal Neoplasms
4
Sarcoma
3
Sarcoma, Ewing
2
Insulin-Like Growth Factor I, Resistance To
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoid Tumor
2
Breast Neoplasms
2
Small Cell Lung Carcinoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Recurrence
1
Rectal Neoplasms
1
Pleural Effusion, Malignant
1
Neuroendocrine Tumors
1
Neoplasms
1
Lymphoma
1
Lung Neoplasms
1
Jaundice
1
Gastrointestinal Neoplasms
1
Endocrine Gland Neoplasms
1
Colonic Neoplasms
1
Adenoma, Islet Cell
1
Adenocarcinoma
1
Interventions
temsirolimus
1
sargramostim
1
ruxolitinib
1
rucaparib
1
pazopanib
1
olaparib
1
eltrombopag
1
cc-486
1
Surveys and Questionnaires
1
Nivolumab
1
Monatide (IMS 3015)
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Doxorubicin
1
Docetaxel
1
Diphenhydramine
1
Cytarabine
1
Cyclophosphamide
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pathologic Complete Response
×
ganitumab
×
Clear all
No trials found.